HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. (NYSE: ANTM) and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are working together to launch the first of its kind pragmatic study to understand the benefits of semaglutide as compared with all other available diabetes drugs in a real-world pragmatic […]Continue Reading ...
Credit: Vera Kratochvil/public domain People who gain weight after they quit smoking may face a temporary increase in the risk of developing type 2 diabetes, with the risk directly proportional to the weight gain, according to a new study from Harvard T.H. Chan School of Public Health. But regardless of weight gain, quitters can reap […]Continue Reading ...
Credit: CC0 Public Domain A research team at the University of North Carolina at Chapel Hill’s Gillings School of Global Public Health found that a well-known gene variant linked to Type 2 diabetes, called transcription Factor-7 like 2 gene, may also predispose someone to being leaner, or having a lower body weight. These findings are […]Continue Reading ...
Only in science fiction novels can scientists predict people’s lifespans. However, researchers have advanced the understanding of those risk factors that adversely affect mortality rates. A new study concludes that women who experienced early menopause lived shorter lives and spent fewer years without diabetes than women who experienced normal or late menopause. Study results are […]Continue Reading ...
Oct 3 2018 New research shows healthcare services and public health strategies aimed at reducing the burden of type 2 diabetes may prove ineffective, unless they address social and cultural factors. Researchers linked factors such as food traditions and traditional gender roles to increasing vulnerability to diabetes in cities, where three-quarters of people with the […]Continue Reading ...
A new study by Australian researchers, out today, is challenging what we know about the causes of diabetes. The new research points to fat tissue as a source of disease, and widens our understanding beyond the traditional focus on liver and pancreas as the main culprits. The findings, uncovered in mice, are published in the […]Continue Reading ...
Corresponding authors, Dr. Sean Hartig, is on the left, and Natasha Chernis. Credit: Baylor College of Medicine About 422 million people around the world, including more than 30 million Americans, have diabetes. Approximately ninety percent of them have type 2 diabetes. People with this condition cannot effectively use insulin, a hormone made by the pancreas […]Continue Reading ...
Oct 9 2018 Liva Healthcare, the digital health platform designed to tackle Type 2 diabetes, has appointed Dr Roger Henderson as UK medical director. Dr Henderson will be responsible for overseeing clinical governance of Liva’s Type 2 diabetes prevention and treatment program which is used by the NHS, leading insurers and pharmaceutical companies. In addition, […]Continue Reading ...
FRIDAY, Oct. 12, 2018 — Among U.S. women, a normally high circulating prolactin concentration is associated with a reduced risk for type 2 diabetes, according to a study published online Oct. 11 in Diabetologia. Jun Li, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues examined the prospective correlation between […]Continue Reading ...
For some healthcare providers – especially those serving racial/ethnic minority and low-income patients – the costs of delivering a new Medicare Diabetes Prevention Program (MDPP) may be much higher than the expected reimbursement, reports a study in the November issue of Medical Care. The journal is published in the Lippincott portfolio by @WKHealth. Payments may […]Continue Reading ...
WEDNESDAY, Oct. 10, 2018 — Intensive blood pressure (BP) therapy is associated with significantly lower risk for cardiovascular events based on data reweighted to better reflect the U.S. adult population with diabetes, according to a study published in the Sept. 11 issue of the Journal of the American College of Cardiology. Seth A. Berkowitz, M.D., […]Continue Reading ...
People with type 1 diabetes are far more likely to develop cardiovascular disease than those without diabetes. Their risks climb even higher if they show signs of hypertension (high blood pressure) or dyslipidemia (unhealthy levels of cholesterol or triglycerides). Interviewing both teens and parents, Joslin Diabetes Center researchers have identified strategies to help teens with […]Continue Reading ...
Oct 9 2018 Diabetes UK’s ‘Making Hospitals Safe for People with Diabetes’ report, released today (08/10/2018), has revealed concerning inadequacies in care for diabetes inpatients. The report calls for hospitals to adopt six key requirements which would make them safe for people with diabetes, lead to significantly improved patient experiences and shorter lengths of stay. […]Continue Reading ...
INDIANAPOLIS, Oct. 4, 2018 /PRNewswire/ — Results from a phase 2b clinical trial of Eli Lilly and Company’s (NYSE: LLY) dual GIP and GLP-1 receptor agonist (GIP/GLP-1 RA, LY3298176) showed strong and clinically meaningful blood sugar reduction and weight loss in people with type 2 diabetes. The six-month data — showing average HbA1c reductions of […]Continue Reading ...
Credit: CC0 Public Domain By blocking a protein, VDAC1, in the insulin-producing beta cells, it is possible to restore their normal function in case of type 2 diabetes. In preclinical experiments, the researchers behind a new study have also shown that it is possible to prevent the development of the disease. The findings are published […]Continue Reading ...
- Health Tip: Know the Risks of Chicken Pox
- Immunotherapy effective against hereditary melanoma
- Researchers reveal new mechanism for how animal cells stay intact | News Center
- Alzheimer's Goes Under the Cryo-Electron Microscope
- Medicare for all? CMS chief warns program has enough problems already
- Metrohm Raman introduces Mira P handheld Raman system
- Expanding the knowledge about hippocampus to better understand cognitive deficits in MS
- Study of Nigerian breast cancer patients reveals prevalence of aggressive molecular features
- Many healthy children may have metabolic risk factors, finds study
- A new antibiotic could be a better, faster treatment for tuberculosis
- “I will not become a Robot Doctor”: A medical student vows to practice compassion
- Study findings may explain sporadic outbreaks of C. difficile infections in hospitals
- Purdue researchers develop new chemical process to find better drug ‘fits’ for patients
- Yale researchers develop way to attack RNA with small-molecule drugs
- New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug
- Alnylam Announces Plan to Initiate Rolling Submission of a New Drug Application and Pursue Full Approval for Givosiran
- Nine cases of polio-like illness suspected in children in illinois
- Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries
- Patients once thought incurable can benefit from high-dose radiation therapy
- Researchers awarded grant to advance testing of experimental heroin vaccine